Conversely, the expression of KYNU, AOX1, KMO, TDO2, ACAT1, DDC, CYPIAI, OGDHL, WASRS1, AFMID, CYP1A2, ASMT, and TPH2 was lower in glioma than normal brain tissue samples. This evidence concerns the gene AFMID and central nervous system cancer.